Skip to main content
AbClon Inc. logo

AbClon Inc. — Investor Relations & Filings

Ticker · 174900 ISIN · KR7174900001 KO Manufacturing
Open in API
Filings indexed 254 across all filing types
Latest filing 2021-02-24 Regulatory Filings
Country KR South Korea
Listing KO 174900

About AbClon Inc.

https://www.abclon.com/en/

AbClon Inc. is a clinical-stage company focused on the research and development of antibody-based therapeutics. The company leverages three core proprietary platforms. The CAR-T platform develops personalized cell therapies for cancer patients by engineering a patient's own immune cells to target and destroy cancer cells, with a focus on blood cancers. The NEST (Novel Epitope Screening Technology) platform is designed to discover antibodies that target unique, previously unaddressed sites on disease proteins, enabling novel therapeutic effects. The AffiMab platform facilitates the development of bispecific antibodies that can simultaneously engage two different disease targets, aiming to maximize therapeutic efficacy in refractory diseases.

Recent filings

Filing Released Lang Actions
기타경영사항(특허권취득)(자율공시)(시스테인으로 변형된 항체 및 이를 이용한 부위-특이적 접합)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from AbClon regarding the acquisition of a patent ('기타 경영사항(특허권 취득)'). It details the patent name, content, and its strategic application in the company's CAR-T platform. Since this is a specific corporate disclosure regarding business operations and intellectual property that does not fit into financial reporting, dividend, or management change categories, it is classified as a general regulatory filing.
2021-02-24 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by AbClon. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2021-02-24 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. It also mentions that the presentation materials will be distributed at the event and made available on the KRX KIND system. Since this is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2021-02-19 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (AbClon) announcing a significant change (over 30%) in revenue or profit structure. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) for material financial changes. It provides key financial highlights and reasons for the change, fitting the definition of an Earnings Release (ER) as it serves as an initial announcement of financial results before the full audit is finalized. FY 2020
2021-02-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of major shareholders (Lee Jong-seo and related parties) in AbClon Inc. and reports changes in their ownership percentages due to the conversion of convertible preferred shares into common shares. This falls under the category of Major Shareholding Notification (MRQ).
2020-12-18 Korean
기타경영사항(자율공시)(전환우선주의 보통주 전환 청구)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from AbClon regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure and share count. According to the provided definitions, 'SHA' (Share Issue/Capital Change) covers announcements regarding new share issues or capital changes, which aligns with the conversion of preferred shares into common stock.
2020-12-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.